The authors noted limitations including reliance on ICD codes to identify NAION, lack of data on diabetes duration prior to Medicare enrollment, and a restricted age range that may limit generalizability
Figure 4 and Additional file 1: Table S5 show the overall effects of the three classes of drugs on cardiorenal endpoints by the network meta-analysis using the frequentist approach
Common edge cases we see in clinic Most Bridge questions have a clear yes-or-no answer
Disclaimer: The author (JK) is neither a pharmacologist nor a specialist who uses GLP-1 drugs, and this blog does not address the efficacy of GLP-1 drugs for weight loss
But more than a year after Empower said they would take steps to ensure the quality of their ingredients, FDA investigators again found Empower was using ingredients labeled not for drug use to make injectable products, according to records from a December 2023 inspection
Fennell for protein reagent generation